DK0781547T3 - Ophthalmisk formulering baseret på natriumhyaluronat til anvendelse i øjen-kirugi - Google Patents

Ophthalmisk formulering baseret på natriumhyaluronat til anvendelse i øjen-kirugi

Info

Publication number: DK0781547T3
Authority: DK; Denmark
Prior art keywords: sodium hyaluronate; eye surgery; ophthalmic formulation; formulation based; ophthalmic
Prior art date: 1995-12-22

Application number

DK96120457T

Other languages

Danish (da)

English (en)

Inventor

Rene-Pierre Buenter

Original Assignee

Trb Chemedica S A

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-12-22

Filing date

1996-12-19

Publication date

2002-08-12

1996-12-19 Application filed by Trb Chemedica S A filed Critical Trb Chemedica S A

2002-08-12 Application granted granted Critical

2002-08-12 Publication of DK0781547T3 publication Critical patent/DK0781547T3/da

Links

229920002385 Sodium hyaluronate Polymers 0.000 title abstract 2
238000009472 formulation Methods 0.000 title abstract 2
239000000203 mixture Substances 0.000 title abstract 2
229940010747 sodium hyaluronate Drugs 0.000 title abstract 2
YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 title abstract 2
238000001356 surgical procedure Methods 0.000 title abstract 2
KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 abstract 1
239000003963 antioxidant agent Substances 0.000 abstract 1
230000003078 antioxidant effect Effects 0.000 abstract 1
239000008363 phosphate buffer Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution

Landscapes

Health & Medical Sciences (AREA)
Ophthalmology & Optometry (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Surgery (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)

DK96120457T 1995-12-22 1996-12-19 Ophthalmisk formulering baseret på natriumhyaluronat til anvendelse i øjen-kirugi DK0781547T3 (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
IT95MI002744A IT1277707B1 (it)	1995-12-22	1995-12-22	Formulazione oftalmica a base di ialuronato di sodio per uso nella chirurgia oculare

Publications (1)

Publication Number	Publication Date
DK0781547T3 true DK0781547T3 (da)	2002-08-12

Family

ID=11372809

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK96120457T DK0781547T3 (da)	1995-12-22	1996-12-19	Ophthalmisk formulering baseret på natriumhyaluronat til anvendelse i øjen-kirugi

Country Status (10)

Country	Link
US (1)	US5880107A (de)
EP (1)	EP0781547B1 (de)
JP (1)	JP4146910B2 (de)
AT (1)	ATE216221T1 (de)
CA (1)	CA2193543C (de)
DE (1)	DE69620724T2 (de)
DK (1)	DK0781547T3 (de)
ES (1)	ES2175020T3 (de)
IT (1)	IT1277707B1 (de)
PT (1)	PT781547E (de)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6541460B2 (en)	1996-08-07	2003-04-01	George D. Petito	Method for use of hyaluronic acid in wound management
US6368585B1 (en) *	1997-03-25	2002-04-09	Pharmacia Ab	Opthalmic compositions and methods
US20030138499A1 (en) *	1998-12-17	2003-07-24	Shah Mandar V.	Stable surgical irrigating solutions
US6533769B2 (en) *	2001-05-03	2003-03-18	Holmen Joergen	Method for use in cataract surgery
US7820194B2 (en)	2001-12-21	2010-10-26	Alcon, Inc.	Combinations of viscoelastics for use during surgery
ITMI20020557A1 (it) *	2002-03-15	2003-09-15	Acraf	Uso di un sale dell'acido l-ascorbico per preparare una composizione farmaceutica per uso topico oftalmico capace di migliorare il livello d
US20040167480A1 (en) *	2003-02-21	2004-08-26	Advanced Medical Optics, Inc.	Administration of multiple viscoelastic solutions with a multi-compartment syringe
FR2861734B1 (fr)	2003-04-10	2006-04-14	Corneal Ind	Reticulation de polysaccharides de faible et forte masse moleculaire; preparation d'hydrogels monophasiques injectables; polysaccharides et hydrogels obtenus
US20050215516A1 (en) *	2004-03-29	2005-09-29	Claudio Bucolo	New free-radical scavenger containing viscoelastic composition, methods of use and package
US20060073184A1 (en) *	2004-09-29	2006-04-06	Bausch & Lomb Inc.	Viscoelastic composition, methods of use and packaging device with anti-oxidant
WO2008042441A1 (en) *	2006-10-03	2008-04-10	Anthrogenesis Corporation	Use of umbilical cord biomaterial for ocular surgery
EP2152743A2 (de) *	2007-05-23	2010-02-17	Allergan, Inc.	Quervernetztes collagen und anwendungen davon
US8318695B2 (en) *	2007-07-30	2012-11-27	Allergan, Inc.	Tunably crosslinked polysaccharide compositions
US8697044B2 (en) *	2007-10-09	2014-04-15	Allergan, Inc.	Crossed-linked hyaluronic acid and collagen and uses thereof
KR101577471B1 (ko)	2007-11-16	2015-12-14	알러간, 인코포레이티드	자색반병의 치료를 위한 조성물 및 방법
US8394784B2 (en)	2007-11-30	2013-03-12	Allergan, Inc.	Polysaccharide gel formulation having multi-stage bioactive agent delivery
US20090143348A1 (en) *	2007-11-30	2009-06-04	Ahmet Tezel	Polysaccharide gel compositions and methods for sustained delivery of drugs
US8394782B2 (en) *	2007-11-30	2013-03-12	Allergan, Inc.	Polysaccharide gel formulation having increased longevity
WO2009084044A1 (en) *	2007-12-27	2009-07-09	D.M.G. Italia Srl	Composition comprising superoxide dismutase and carboxv methyl beta-1,3 glucan
US8357795B2 (en)	2008-08-04	2013-01-22	Allergan, Inc.	Hyaluronic acid-based gels including lidocaine
AU2009288118B2 (en)	2008-09-02	2014-12-11	Allergan, Inc.	Threads of hyaluronic acid and/or derivatives thereof, methods of making thereof and uses thereof
US20100104654A1 (en) *	2008-10-27	2010-04-29	Allergan, Inc.	Prostaglandin and prostamide drug delivery systems and intraocular therapeutic uses thereof
JP4885245B2 (ja) *	2009-01-15	2012-02-29	日本航空電子工業株式会社	Ｒｄコンバータ及び角度検出装置
JP2013513622A (ja) *	2009-12-14	2013-04-22	ユニバーシティオブマサチューセッツ	白内障及び老眼を阻害する方法
US20110172180A1 (en)	2010-01-13	2011-07-14	Allergan Industrie. Sas	Heat stable hyaluronic acid compositions for dermatological use
US9114188B2 (en)	2010-01-13	2015-08-25	Allergan, Industrie, S.A.S.	Stable hydrogel compositions including additives
US20110171311A1 (en) *	2010-01-13	2011-07-14	Allergan Industrie, Sas	Stable hydrogel compositions including additives
US20110171310A1 (en) *	2010-01-13	2011-07-14	Allergan Industrie, Sas	Hydrogel compositions comprising vasoconstricting and anti-hemorrhagic agents for dermatological use
CA2792729C (en) *	2010-03-12	2016-06-28	Allergan Industrie, Sas	Fluid compositions for improving skin conditions
DK2550027T4 (da)	2010-03-22	2019-05-13	Allergan Inc	Tværbundne polysaccharid- og protein-polysaccharid-hydrogeler til blødvævsforøgelse
US8889123B2 (en)	2010-08-19	2014-11-18	Allergan, Inc.	Compositions and soft tissue replacement methods
US8883139B2 (en)	2010-08-19	2014-11-11	Allergan Inc.	Compositions and soft tissue replacement methods
US8697057B2 (en)	2010-08-19	2014-04-15	Allergan, Inc.	Compositions and soft tissue replacement methods
US9005605B2 (en)	2010-08-19	2015-04-14	Allergan, Inc.	Compositions and soft tissue replacement methods
US9393263B2 (en)	2011-06-03	2016-07-19	Allergan, Inc.	Dermal filler compositions including antioxidants
KR102015676B1 (ko)	2011-06-03	2019-10-21	알러간, 인코포레이티드	항산화제를 포함하는 피부 충전제 조성물
US9408797B2 (en)	2011-06-03	2016-08-09	Allergan, Inc.	Dermal filler compositions for fine line treatment
US20130096081A1 (en)	2011-06-03	2013-04-18	Allergan, Inc.	Dermal filler compositions
US20130244943A1 (en)	2011-09-06	2013-09-19	Allergan, Inc.	Hyaluronic acid-collagen matrices for dermal filling and volumizing applications
US9662422B2 (en)	2011-09-06	2017-05-30	Allergan, Inc.	Crosslinked hyaluronic acid-collagen gels for improving tissue graft viability and soft tissue augmentation
ES2846724T3 (es) *	2012-12-19	2021-07-29	Novartis Ag	Formulaciones de inhibidores de LFA-1
AT514540A1 (de) *	2013-06-18	2015-01-15	Apomedica Pharmazeutische Produkte Gmbh	Ophthalmische Zusammensetzung
JP6357228B2 (ja)	2013-07-10	2018-07-11	マトリックスバイオロジーインスティテュート	高い弾性を有するヒアルロナンの組成物およびその使用
WO2015125921A1 (ja) *	2014-02-20	2015-08-27	わかもと製薬株式会社	保存効力を有する医薬用水性組成物
EP3200838B1 (de)	2014-09-30	2019-09-18	Allergan Industrie, SAS	Stabile hydrogelzusammensetzungen mit additiven
WO2016128783A1 (en)	2015-02-09	2016-08-18	Allergan Industrie Sas	Compositions and methods for improving skin appearance
BR112018003031B1 (pt)	2015-08-18	2023-12-26	Astellas Institute For Regenerative Medicine	Solução salina de vida útil prolongada, preparação celular, seus usos, método de obtenção e armazenamento de preparação celular, composição farmacêutica e kit
CN108135926A (zh)	2015-09-24	2018-06-08	基质生物研究所	高弹性透明质酸组合物及其使用方法
KR20190068575A (ko) *	2016-10-14	2019-06-18	이콤 메디칼 게엠베하	안구 표면 항상성의 확립, 회복 및 보존 방법
CN111386135B (zh) *	2017-11-22	2022-11-08	鲍希与洛姆伯股份有限公司	眼科粘弹性组合物
CN113354757B (zh) *	2021-06-26	2022-04-08	上海加新生物科技有限公司	一种小分子透明质酸钠的制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4141973A (en)	1975-10-17	1979-02-27	Biotrics, Inc.	Ultrapure hyaluronic acid and the use thereof
US5409904A (en) *	1984-11-13	1995-04-25	Alcon Laboratories, Inc.	Hyaluronic acid compositions and methods
US4886786A (en) *	1985-08-01	1989-12-12	Lindstrom Richard L	Additive for irrigation solution or surgical solution
IL80298A (en)	1986-10-14	1993-01-31	Res & Dev Co Ltd	Eye drops
US4920104A (en) *	1988-05-16	1990-04-24	Medchem Products, Inc.	Sodium hyaluronate composition
US5204331A (en) *	1990-06-29	1993-04-20	Santen Pharmaceutical Co., Ltd.	Composition for debridement of retained lens materials
WO1994007505A1 (en) *	1991-07-03	1994-04-14	Norpharmco Inc.	Use of hyaluronic acid and forms to prevent arterial restenosis
JPH06107538A (ja) *	1992-03-31	1994-04-19	Shiseido Co Ltd	角膜移植用眼球保存液
JPH05310580A (ja) *	1992-04-30	1993-11-22	Shiseido Co Ltd	眼内灌流用液剤

1995
- 1995-12-22 IT IT95MI002744A patent/IT1277707B1/it active IP Right Grant
1996
- 1996-12-19 DK DK96120457T patent/DK0781547T3/da active
- 1996-12-19 PT PT96120457T patent/PT781547E/pt unknown
- 1996-12-19 AT AT96120457T patent/ATE216221T1/de active
- 1996-12-19 EP EP96120457A patent/EP0781547B1/de not_active Expired - Lifetime
- 1996-12-19 ES ES96120457T patent/ES2175020T3/es not_active Expired - Lifetime
- 1996-12-19 DE DE69620724T patent/DE69620724T2/de not_active Expired - Lifetime
- 1996-12-20 US US08/770,331 patent/US5880107A/en not_active Expired - Lifetime
- 1996-12-20 CA CA002193543A patent/CA2193543C/en not_active Expired - Lifetime
- 1996-12-20 JP JP34218496A patent/JP4146910B2/ja not_active Expired - Fee Related

Also Published As

Publication number	Publication date
EP0781547A1 (de)	1997-07-02
IT1277707B1 (it)	1997-11-11
DE69620724T2 (de)	2002-11-21
JP4146910B2 (ja)	2008-09-10
JPH09216826A (ja)	1997-08-19
DE69620724D1 (de)	2002-05-23
ES2175020T3 (es)	2002-11-16
US5880107A (en)	1999-03-09
ITMI952744A0 (de)	1995-12-22
PT781547E (pt)	2002-09-30
EP0781547B1 (de)	2002-04-17
ITMI952744A1 (it)	1997-06-22
CA2193543A1 (en)	1997-06-23
CA2193543C (en)	2006-02-21
ATE216221T1 (de)	2002-05-15

Publication	Publication Date	Title
DK0781547T3 (da)	2002-08-12	Ophthalmisk formulering baseret på natriumhyaluronat til anvendelse i øjen-kirugi
ATE482675T1 (de)	2010-10-15	Optisches implantat für die hornhaut
MX9702349A (es)	1997-06-28	Usos de derivado de 9-deoxi prostaglandina para tratar glaucoma.
DE69420196D1 (de)	1999-09-30	Ophtalmologische Vorrichtung für den vorderen Augenbereich
LV10688A (lv)	1995-06-20	Pretalergisks sastavs oftalmologijai vai deguna slimibam
CA2295061A1 (en)	1999-01-21	Storage-stable ophthalmic compositions comprising diclofenac and ofloxacin
WO2003022174A3 (en)	2003-11-06	Intraocular lens extracting device
CA2436269A1 (en)	2002-06-27	Artificial tear composition containing a combination of three demulcents
DE60108727D1 (de)	2005-03-10	Farbige visko-elastische zusammensetzung
WO1998039293A3 (en)	1998-11-05	13-thia prostaglandins for use in glaucoma therapy
WO2000018316A3 (en)	2000-11-16	Sustained release, and comfortable ophthalmic composition and method for ocular therapy
AU5446299A (en)	2000-03-21	Medicinal compositions for treating eye diseases
AU2002357972A1 (en)	2003-07-09	Heparin-containing ophthalmic agent
DK1083929T3 (da)	2007-06-11	Anvendelse af anabolske stoffer
NO973343D0 (no)	1997-07-18	Antiinflammatoriske öyedråper
NO951989L (no)	1995-05-19	Anvendelse av amidoaminer i öyepreparater
ES2069823T3 (es)	1995-05-16	Tratamiento de la hipertension ocular con una combinacion sinergica ocular.
BR0115154A (pt)	2006-06-06	material viscoelástico transicional não-aspirante para uso em cirurgia
DE69100171D1 (de)	1993-08-19	Synergistische kombination zur ophthalmischen verwendung.
ATE202922T1 (de)	2001-07-15	Ophthalmische cromolyn-gelzubereitung
DE69914066D1 (de)	2004-02-12	Augenspüllösung
HU9301364D0 (en)	1993-09-28	Homo-prostaglandines applicables for treatment of hypertension in eyes
IT234988Y1 (it)	2000-03-31	Scivolasta correttore per protesi oculare in caso di assimetria anatomica delle orecchie.
MX9600140A (es)	1998-11-29	Uso de derivados de tocoferilo de vitamina e en composiciones oftalmicas.
UA29334A (uk)	2000-10-16	Очні краплі